Its premise is an upstream intervention targeting substantial weight reduction to improve key risk factors with the aim to avoid potential downstream complications from multiple co-morbidities, e.g., hypertension, dyslipidaemia, heart failure, kidney disease, NAFLD/NASH or diabetes
[3] One more clever bit: its been tweaked at one end to survive longer in the body
after an initial 5-min warm up, the running speed was gradually increased to 25 m/min, which was maintained for 30 min
Dose escalation and dry mouth flares Each time you increase your dose, dry mouth may temporarily worsen
Pending indications: The FDA is currently reviewing Mounjaro for MACE risk reduction
Thank you to our sponsors AGZ by AG1: Function: Rorra: Timestamps (00:00:00) David Spiegel (00:00:20) What is Hypnosis